Johns Hopkins researchers have invented a new class of immunotherapeutic agents that are more effective at harnessing the power of the immune system to fight cancer. Their approach results in significant inhibition of tumor growth, even against cancers which do not respond to existing immunotherapies used in the clinic. In collaboration with Insilico Medicine, a Baltimore-based leader in artificial intelligence for drug discovery, the team reports their results this week in Nature Communications.
Quite a number of people develop nearsightedness or farsightedness during their lifetimes. "Nanodrops," a new eye drop developed by Israeli ophthalmologists, has successfully fixed corneas in pig eyes, and could potentially do the same for people.
Sepsis, a potentially life-threatening complication of infection, is currently treated with antibiotics which kill the infection-causing bacteria. But research out of the University of Pennsylvania spotlights an alternative approach: Delivering certain gut microbes to mice boosted antibody levels in mice, protecting them against the widespread inflammation that can lead to sepsis.
Two Indian engineers have invented a portable photo-therapy device which allows parents treat jaundice within the comfort of their homes. The Neolight system is based on blue light-emitting diodes (LED) that can be used at home. It works on solar as well as battery power. The photo device can produce different wavelengths of light for the treatment of varying severities of infant jaundice.
Big data is showering its miraculous effects on a range of industries. And the healthcare industry is not left out of the bandwagon. Precision medicine is at the brink of a revolution in individualizing treatment, and healthcare professionals are devising ways to prevent and treat diseases with granularity down to a single patient’s genome.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.